Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy

We only have this paper's title and publication details.

Correction highlights association between plasma DNase levels and clinical outcomes in testicular germ cell tumor patients, suggesting a potential for improved treatments.